Please assess the completion status of the following clinical trial:

Trial Title: Magnesium Sulfate in Obese Preeclamptics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women who are ages 18-45~* 32-42 weeks' pregnant~* Prescribed magnesium sulfate for preeclampsia~* BMI ≥35 kg/m2~Exclusion Criteria:~* Pregnant women \< 32 weeks' pregnant~* Women who are on dialysis

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- MgSO4 4g load, 1g/hr infusion (Type: ACTIVE_COMPARATOR): Once their obstetrician prescribes magnesium sulfate, participant will be assigned by 50/50 chance to one of two treatment regimens. Participant will be assigned to either a dose of 4 g at the start, followed by 1g every hour; or a dose of 6 g at the start, followed by 2g every hour until treatment for preeclampsia is complete.
- MgSO4 6g load, 2g/hr infusion (Type: EXPERIMENTAL): Once their obstetrician prescribes magnesium sulfate, participant will be assigned by 50/50 chance to one of two treatment regimens. Participant will be assigned to either a dose of 4 g at the start, followed by 1g every hour; or a dose of 6 g at the start, followed by 2g every hour until treatment for preeclampsia is complete.

Based on this trial design, predict the completion outcome and termination type (if applicable).